Marc E Goldberg - Director, Enanta Pharmaceuticals Inc
As of December 6, 2013
What is Marc E Goldberg's Net Worth?
The current estimated net worth of Enanta Pharmaceuticals Inc's Director, Marc E Goldberg, is estimated to be about $24.81M . Marc E Goldberg owns about 547,606 units of Enanta Pharmaceuticals Inc common stock. In the last 9 months at Enanta Pharmaceuticals Inc, Marc E Goldberg has sold an estimated value of $1.48M worth.
What is Marc E Goldberg's Past Insider Trading?
Marc E Goldberg's largest sale order was 50,000 units , worth over $1.29M on November 27, 2013. In total, Marc E Goldberg has made about 3 transactions over 9 months of their time at Enanta Pharmaceuticals Inc. Marc E Goldberg usually trades in December, March and November, with the busiest year in 2013. The most recent transaction was a sale order of 6,861 units , worth over $191.61K on December 6, 2013.
Marc E Goldberg
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Marc E Goldberg's' Mailing Address?
- Mailing address is C/o Enanta Pharmaceuticals, Inc. 500 Arsenal Street Watertown MA 02472 MA
What are Enanta Pharmaceuticals Inc's Past Insider Trades?
Enanta Pharmaceuticals Inc's most recent insider trade came on April 5, 2022 by Nathalie Adda who sold 83,344 units worth $5.97M . In the last 9 years, insiders at Enanta Pharmaceuticals Inc have sold an estimated value of $97.83M and bought an estimated value of $18.01M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Paul Mellett, Treasurer and CFO, Jay Luly, President and CEO, and Nathaniel S. Gardiner As Attorney-In-Fact, Sr. VP & CSO .
ENANTA PHARMACEUTICALS INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||